A solid comprehension of the heterogeneity in GBA1-PD across populations will facilitate the inclusion of diverse populations in clinical trials, enhance our ability to reach new research milestones, and possibly pave the way for novel therapeutic targets in PD research. The gene discussed is GBA1; the disease is Parkinson disease.